183. Impact of Revised Piperacillin/Tazobactam Clinical Breakpoints on Enterobacterales Isolates Identified in Blood Cultures

BACKGROUND: Enterobacterales are a significant cause of bloodstream infections (BSI) in hospitalized patients. Prior evidence suggests that treatment with piperacillin/tazobactam may not be ideal for BSI. Piperacillin/tazobactam clinical breakpoints were recently updated by the Clinical and Laborato...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Nicholas M, Houlihan, Joyce H, Varughese, Christy A, Hodgson, Hayley A, Shankaran, Shivanjali, Won, Sarah Y, Hayden, Mary K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752047/
http://dx.doi.org/10.1093/ofid/ofac492.261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752047/
http://dx.doi.org/10.1093/ofid/ofac492.261

Ejemplares similares